Fluorescence-guided surgery is an intraoperative optical imaging method that provides
surgeons with real-time guidance for the delineation of tumours. Currently, in phase 1 and 2 …

Background Extent of resection is considered to be a prognostic factor in neuro‐oncology.
Intraoperative imaging technologies are designed to help achieve this goal. It is not clear …

OBJECTIVE High-grade gliomas (HGGs) continue to carry poor prognoses, and patient
outcomes depend heavily on the extent of resection (EOR). The utility of conventional image …

Background Surgical resection of high-grade gliomas (HGG) is standard therapy because it
imparts significant progression free (PFS) and overall survival (OS). However, HGG-tumor …

Glial tumors are one of the most common lesions of the central nervous system. Despite the
implementation of appropriate treatment, the prognosis is not successful. As shown in the …

Background There is strong concern about the costs associated with adding tumor-treating
fields (TTF) therapy to standard first-line treatment for glioblastoma (GBM). Hence, we aimed …

OBJECTIVE Only one phase III prospective randomized study, published in 2006, has
assessed the performance of 5-aminolevulinic acid (5-ALA) fluorescence–guided surgery …

Glioblastoma (GBM) is a highly aggressive disease and is associated with poor prognosis
despite treatment advances in recent years. Surgical resection of tumor remains the main …

Introduction Glioblastoma is the most common primary brain tumor in adults. Standard of
care includes maximal surgical resection of the tumor followed by concurrent chemotherapy …

Background Multiple studies have identified the prognostic relevance of extent of resection
in the management of glioma. Different intraoperative technologies have emerged in recent …